回歡迎頁 聯絡我們 院內導覽
 

 
醫師專長查詢
藥品辨識系統
交通示意
出入口開放時間
特約停車場
醫師簡介
留言版
導覽系統
相關連結
 

 

醫師簡介  

   主頁 > 諮詢服務 > 醫師專長查詢

  • 姓名:楊志仁
  • 科別:內科
  • 地址:高雄市前金區中華三路68號 
  • 現任:
    高雄市立大同醫院院長室醫務秘書
    高雄市立大同醫院胸腔內科 主治醫師
    高雄醫學大學醫學院 教授
    高雄醫學大學後醫學系 副系主任

上一頁

 學歷
高雄醫學大學 醫學士
高雄醫學大學 醫學研究所 博士畢業
 經歷
高雄醫學大學附設醫院 內科住院醫師
高雄醫學大學附設醫院 內科總住院醫師
高雄醫學大學附設醫院 一般內科主治醫師
高雄醫學大學附設醫院 胸腔內科主治醫師
文雄醫院 加護病房及呼吸照護病房主治醫師
署立恆春旅遊醫院 胸腔內科 主治醫師
高雄市立大同醫院 醫務秘書
 臨床專業
胸腔內科/呼吸道疾病
 診療項目
肺癌、氣喘、慢性阻塞性肺病、重症醫學、肺部一般疾患
 執 照
內科醫學會 內科專科醫師 內科專科指導醫師
胸腔暨重症醫學會 胸腔專科醫師 胸腔專科指導醫師
胸腔暨重症醫學會 重症專科醫師 重症專科指導醫師
臺灣肺癌醫學會 肺癌專科醫師 肺癌專科指導醫師
 學術職位
高雄醫學大學 醫學院 醫學系暨呼吸治療學系 副教授
 醫院職位
高雄市立大同醫院 院長室醫務秘書
高雄市立大同醫院胸腔內科 主治醫師

 期刊論文
Pin1 Is Involved in HDAC6-mediated Cancer Cell Motility. Hsiang-Hao Chuang, Ming-Shyan Huang, Pei-Hui Wang,Yu-Peng Liu, Michael Hsiao, and Chih-Jen Yang*
Int J Med Sci. (accept) 2018 Aug.
IF 2.316. 36/155 (23.22%) (MEDICINE, GENERAL & INTERNAL)

Tracheoesophageal Fistula in a Patient with Advanced Non-Small Cell Lung Cancer Who Received Chemoradiotherapy and Ramucirumab.
Yen-Lung Lee, Jui-Feng Hsu, Chih-Jen Yang*
J Thorac Oncol (accept) 2018 Aug.
SCI; IF 10.336 Ranking 4/59= 6.7% in Respirology

Regression of a metastatic lung mass after receiving whole brain irradiation: Can the abscopal effect cross the blood-brain barrier? Chuang CH, Hsu JF, Shen YT, Yang CJ*.
Asia Pac J Clin Oncol. 2018 Jul 8.
SCI; IF 1.959; Ranking=160/217 = 73.7% in Oncology

Roles of Aldolase Family Genes in Human Cancers and Diseases. Yu-Chan Chang, Yi-Chieh Yang, Chia-Ping Tien, Chih-Jen Yang* and Michael Hsiao*. (Co-corresponding author)
Trends in Endocrinology and Metabolism (Invited review).
SCI; IF 10.893 (6/138, 4.34% in Endocrinology and Metabolism)

Empiric Anti-Tuberculosis Treatment Is Not Always a Right Way In Patients Who Had Have Poorly Controlled Diabetes Mellitus and Presented with Pulmonary Cavities Over Upper Lungs in Tuberculosis Endemic Countries. Chi-Hung Cheng, Chih-Jen Yang*.
Epidemiol Infect. 2018 May 8:1-2.
SCI; IF=2.07; Ranking=72/176 =40% in Public, Environmental & Occupational Health)

Salmonella Overcomes Drug Resistance in Tumor through P-glycoprotein Downregulation.
Chih-Jen Yang, Wen-Wei Chang, Song-Tao Lin, Man-Chin Chen, Che-Hsin Lee*
Int J Med Sci. 2018 Mar 9;15(6):574-579
SCI; IF= 2.316. Ranking=36/155 (23.22%) (MEDICINE, GENERAL & INTERNAL)

The clinical efficacy of Afatinib 30 mg daily as starting dose may not be inferior to Afatinib 40 mg daily in patients with stage IV lung Adenocarcinoma harboring exon 19 or exon 21 mutations.
Yang CJ, Tsai MJ, Hung JY, Lee MH, Tsai YM, Tsai YC, Hsu JF, Liu TC, Huang MS, Chong IW*.
BMC Pharmacol Toxicol. 2017 Dec 13;18(1):82
SCI; IF=2.288; Ranking= 142/256=55.4% in PHARMACOLOGY & PHARMACY

Reverse epithelial-mesenchymal transition contributes to the regain of drug sensitivity in tyrosine kinase inhibitor-resistant non-small cell lung cancer cells. Lee AF, Chen MC, Chen CJ, Yang CJ*, Huang MS*, Liu YP*. PLoS One. 2017 Jul 6;12(7):e0180383. (*corresponding author)
SCI; IF=2.806; Ranking=15/64=23% in MULTIDISCIPLINARY SCIENCES

The salvage therapy in lung adenocarcinoma initially harbored susceptible EGFR mutation and acquired resistance occurred to the first-line gefitinib and second-line cytotoxic chemotherapy. Yang CJ, Hung JY, Tsai MJ, Wu KL, Liu TC, Chou SH, Lee JY, Hsu JS, Huang MS, Chong IW*.
BMC Pharmacol Toxicol. 2017 May 10;18(1):21. (First author)
SCI; IF=2.288; Ranking= 142/256=55.4% in PHARMACOLOGY & PHARMACY

Feedback regulation of ALDOA activates the HIF-1α/MMP9 axis to promote lung cancer progression. Chang YC, Chan YC, Chang WM, Lin YF, Yang CJ, Su CY, Huang MS, Wu ATH, Hsiao M*.
Cancer Lett. 2017 Sep 10;403:28-36.
SCI; IF=6.375; Ranking= 25/217= 11.5 % in ONCOLOGY

The inhibition of indoleamine 2, 3-dioxygenase 1 by connexin 43
Han-Chen Lin, Chih-Jen Yang, Yu-Diao Kuan , Wei-Kuang Wang, Wen-Wei Chang, Che-Hsin Lee.
Int J Med Sci. 2017 Sep 19;14(12):1181-1188.
SCI; IF=2.316 (in press) 36/155 (23.22%) (MEDICINE, GENERAL & INTERNAL)

Convex border of peripheral non-small cell lung cancer on CT images as a potential indicator of pleural invasion. Hsu JS, Jaw TS, Yang CJ, Lin SF, Shih MP, Chou SH, Chong IW, Lin MY, Chiang IC.
Medicine (Baltimore). 2017 Oct;96(42):e7323
SCI; IF=1.8.

Decrease of FSTL1-BMP4-Smad signaling predicts poor prognosis in lung adenocarcinoma but not in squamous cell carcinoma. Chiou J, Su CY, Jan YH, Yang CJ, Huang MS, Yu YL, Hsiao M.
Sci Rep. 2017 Aug 29;7(1):9830.
SCI; IF=4.259; Ranking= 10/164=15.6% in MULTIDISCIPLINARY SCIENCES

The opposite prognostic effect of NDUFS1 and NDUFS8 in lung cancer reflects the oncojanus role of mitochondrial complex I. Su CY, Chang YC, Yang CJ, Huang MS, Hsiao M.
Sci Rep. 2016 Aug 12;6:31357.
SCI; IF=4.259; Ranking= 10/164=15.6% in MULTIDISCIPLINARY SCIENCES

Risk factors for pneumonia among patients with Parkinson's disease: a Taiwan nationwide population-based study. Chang YP, Yang CJ, Hu KF, Chao AC, Chang YH, Hsieh KP, Tsai JH, Ho PS, Lim SY. Neuropsychiatr Dis Treat. 2016 Apr 27;12:1037-46.
SCI; IF=2.198; Ranking= 109/194=56.2% in CLINICAL NEUROLOGY

Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients. Tsai MJ, Wu PH, Sheu CC, Hsu YL, Chang WA, Hung JY, Yang CJ, Yang YH, Kuo PL, Huang MS.
Sci Rep. 2016 Apr 7;6:23979.
SCI; IF=4.259; Ranking= 10/164=15.6% in MULTIDISCIPLINARY SCIENCES

Pemetrexed had significantly better clinical efficacy in patients with stage IV lung adenocarcinoma with susceptible EGFR mutations receiving platinum-based chemotherapy after developing resistance to the first-line gefitinib treatment. Yang CJ, Tsai MJ, Hung JY, Liu TC, Chou SH, Lee JY, Hsu JS, Tsai YM, Huang MS, Chong IW. Onco Targets Ther. 2016 Mar 16;9:1579-87
SCI; IF=2.612; Ranking= 61/160=38.1% in BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Poorer prognosis in Taiwanese female ever smokers with stage IV lung adenocarcinoma who were readministered a tyrosine kinase inhibitor. Yang CJ, Tsai MJ, Hung JY, Tsai YM, Lee JY, Chou SH, Liu TC, Shen MC, Huang MS, Chong IW.
Onco Targets Ther. 2016 Mar 15;9:1511-8
SCI; IF=2.612; Ranking= 61/160=38.1% in BIOTECHNOLOGY & APPLIED MICROBIOLOGY

The nucleolar protein NIFK promotes cancer progression via CK1α/β-catenin in metastasis and Ki-67-dependent cell proliferation. Lin TC, Su CY, Wu PY, Lai TC, Pan WA, Jan YH, Chang YC, Yeh CT, Chen CL, Ger LP, Chang HT, Yang CJ, Huang MS, Liu YP, Lin YF, Shyy JY, Tsai MD, Hsiao M.
Elife. 2016 Mar 17;5. pii: e11288.
SCI; IF=7.725; Ranking=4/85=4.7% in BIOLOGY

Acute respiratory distress syndrome and acute myocarditis developed in a previously healthy adult with influenza B. Chang HL, Hsu JF, Tsai YM, Lin SY, Kuo HF, Yang CJ*.
BMC Pulm Med. 2016 Jan 4;16:1.
SCI; IF=2.435; Ranking=34/59=57.6% in Respiratory system (*corresponding author)

Long-acting Inhaled Bronchodilator and Risk of Vascular Events in Patients With Chronic Obstructive Pulmonary Disease in Taiwan Population. Tsai MJ, Chen CY, Huang YB, Chao HC, Yang CJ, Lin PJ, Tsai YH. Medicine (Baltimore). 2015 Dec;94(51):e2306.
SCI; IF=1.804; Ranking=57/155=36.8% in MEDICINE, GENERAL & INTERNAL

HIP1 is an Early-stage Prognostic Biomarker of Lung Adenocarcinoma and Suppresses Metastasis via Akt-mediated EMT. Hsu CY, Lin CH, Jan YH, Su CY, Yao YC, Cheng HC, Hsu TI, Wang PS, Su WP, Yang CJ, Huang MS, Calkins MJ, Hsiao M, Lu PJ.
Am J Respir Crit Care Med. 2016 Apr 15;193(8):869-80
SCI; IF=13.204; Ranking=2/59=3.4% in Respiratory system

GIT1 promotes lung cancer cell metastasis through
modulating Rac1/Cdc42 activity and is associated with poor prognosis. Chang JS, Su CY, Yu WH, Lee WJ, Liu YP, Lai TC, Jan YH, Yang YF, Shen CN, Shew JY, Lu J, Yang CJ, Huang MS, Lu PJ, Lin YF, Kuo ML, Hua KT, Hsiao M.
Oncotarget. 2015 Nov 3;6(34):36278-91
SCI; IF=5.168; Ranking=44/217=20% in ONCOLOGY

Port type is a possible risk factor for implantable venous access port-related bloodstream infections and no sign of local infection predicts the growth of gram-negative bacilli. Hsu JF, Chang HL, Tsai MJ, Tsai YM, Lee YL, Chen PH, Fan WC, Su YC, Yang CJ*.
World J Surg Oncol. I 2015 Sep 30;13:288.
SCI; IF=1.60; Ranking=180/217=82.9% in ONCOLOGY

Nuclear HDAC6 inhibits invasion by suppressing NF-κB/MMP2 and is inversely correlated with metastasis of non-small cell lung cancer. Chih-Jen Yang, Yu-Peng Liu, Hong-Ying Dai, Yow-Ling Shiu, Chia-Jung Tsai, Ming-Shyan Huang*, and Yao-Tsung Yeh* (SCI).
Oncotarget IF 6.359. 20/211, 9.4%, 2015 Oct 6;6(30):30263-76.
SCI; IF=5.168; Ranking=44/217=20% in ONCOLOGY

Plasminogen Activator Inhibitor-2 Plays a Leading Prognostic Role among Protease Families in Non-Small Cell Lung Cancer. Su CY, Liu YP, Yang CJ, Lin YF, Chiou J, Chi LH, Lee JJ, Wu AT, Lu PJ, Huang MS, Hsiao M.
PLoS One. 2015 Jul 31;10(7):e0133411.
SCI; IF=2.806; Ranking=15/64=23% in MULTIDISCIPLINARY SCIENCES

Erectile Dysfunction in Patients with Sleep Apnea - A Nationwide Population-Based Study. Chen CM, Tsai MJ, Wei PJ, Su YC, Yang CJ, Wu MN, Hsu CY, Hwang SJ, Chong IW, Huang MS.
PLoS One. 2015 Jul 15;10(7):e0132510.
SCI; IF=2.806; Ranking=15/64=23% in MULTIDISCIPLINARY SCIENCES

Liver metastasis predicts poorer prognosis in stage IV lung adenocarcinoma patients receiving first-line gefitinib. Wu KL, Tsai MJ, Yang CJ, Chang WA, Hung JY, Yen CJ, Shen CH, Kuo TY, Lee JY, Chou SH, Liu TC, Chong IW, Huang MS.
Lung Cancer. 2015 May;88(2):187-94.
SCI; IF=4.294; Ranking= 59/217=27% in ONCOLOGY

Correlation between EGFR mutation status and computed tomography features in patients with advanced pulmonary adenocarcinoma.Hsu JS, Huang MS, Chen CY, Liu GC, Liu TC, Chong IW, Chou SH, Yang CJ*.
J Thorac Imaging. 2014 Nov;29(6):357-63
SCI; IF=2.010; Ranking= 61/126=48.4% in RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Metformin decreases lung cancer risk in diabetic patients in a dose-dependent manner. Tsai MJ, Yang CJ, Kung YT, Sheu CC, Shen YT, Chang PY, Huang MS, Chiu HC.
Lung Cancer. 2014 Nov;86(2):137-43.
SCI; IF=4.294; Ranking= 59/217=27% in ONCOLOGY

Squalene synthase induces tumor necrosis factor receptor 1 enrichment in lipid rafts to promote lung cancer metastasis. Yang YF, Jan YH, Liu YP, Yang CJ, Su CY, Chang YC, Lai TC, Chiou J, Tsai HY, Lu J, Shen CN, Shew JY, Lu PJ, Lin YF, Huang MS, Hsiao M. Am J Respir Crit Care Med. 2014 Sep 15;190(6):675-87.
SCI; IF=13.204; Ranking=2/59=3.4% in Respiratory system

MTAP Is An Independent Prognosis Marker and the Concordant Loss of MTAP and p16 Expression Predicts Short Survival in Non-small Cell Lung Cancer Patient. Su CY, Chang YC, Chan YC, Lin TC, Huang MS, Yang CJ*, Michael Hsiao* Eur J Surg Oncol. 2014 Sep;40(9):1143-50
SCI; IF=3.522; Ranking=31/197=15.74% in surgery

Successful Treatment of Lipoid Pneumonia with Steroid – A Case Report and Literature Review Juan HL, Yang CJ, Yin HL, Wang TH, Hwang JJ, Huang MS Thorac Med 2014; 29(2);118-125 ISSN: Case Report

Lung tumor-associated Dendritic cell-derived Resistin Promoted Cancer Progression by Increasing Wolf–Hirschhorn Syndrome Candidate 1/Twist Pathway. Kuo CH, Chen KF, Chou SH, Huang YF, Wu CY, Chen YW, Yang CJ, Hung JY*, Huang MS* Carcinogenesis. 2013 Nov;34(11):2600-9. (IF:5.266; Ranking:34/202=16.831%;Q1); Category: Oncology SCI; Original articles; PMID: 23955539

The Impact of Inappropriate Antibiotics on Bacteremia Patients in a Community Hospital in Taiwan: An Emphasis on the Impact of Referral Information for Cases from a Hospital Affiliated Nursing Home. Yang CJ, Chung YC, Chen TC, Chang HL, Tsai YM, Huang MS, Chen YH, Lu PL.BMC Infect Dis. 2013 Oct 24;13:500. (IF:2.561; Ranking:35/70=50%; Q3); Category: Infectious Diseases SCI: Original articles; PMID:24156241

Targeting the XIAP/caspase-7 Complex Selectively Kills Caspase-3-deficient Malignancies.Lin YF, Lai TC, Chang CK, Chen CL, Huang MS, Yang CJ, Liu HG, Dong JJ, Chou YA, Teng KH, Chen SH, Tian WT, Jan YH, Hsiao M, Liang PH.J Clin Invest. 2013 Sep 3;123(9):3861-75. (IF:13.765; Ranking:5/122=4.098%; Q1); Category: Medicine, Resarch & Experimental SCI: Original articles; PMID:23979166

Adjusting diffusing capacity of the lung for carbon monoxide for haemoglobin level. Tsai MJ, Yang CJ, Hwang JJ, Huang MS. Eur Respir J. 2013 Feb;41(2):489. (IF:7.125; Ranking:4/53=7.547%; Q1); Category: Respiratory System SCI: Original articles;

Fucosyltransferase 8 as a functional regulator of nonsmall cell lung cancer. Chen CY, Jan YH, Juan YH, Yang CJ, Huang MS, Yu CJ, Yang PC, Hsiao M, Hsu TL, Wong CH. Proc Natl Acad Sci U S A. 2013 Jan 8;110(2):630-5.(IF:9.809; Ranking: 4/55=7.272%; Q1); Category: Multidisciplinary SciencesSCI: Original articles; PMID:23267084

Outcomes of the patients in the respiratory care center are not associated with the seniority of the caring resident. Tsai MJ, Huang JY, Wei PJ, Wang CY, Yang CJ, Wang TH, Hwang JJ. Kaohsiung J Med Sci. 2013 Jan;29(1):43-9. (IF:0.805; Ranking:101/122=82.786%; Q4); Category: Medicine, Research & ExperimentalSCI: Original articles; PMID:23257256

Cisplatin Selects for Multidrug-resistant CD133+ Cells in Lung Adenocarcinoma by Activating Notch Signaling. Liu YP, Yang CJ, Huang MS, Yeh CT, Wu AT, Lee YC, Lai TC, Lee CH, Hsiao YW, Lu J, Shen CN, Lu PJ, Hsiao M.Cancer Res. 2013 Jan 1;73(1):406-16.(IF:9.284; Ranking:10/202=4.95%; Q1); Category: OncologySCI: Original articles; PMID:23135908

Percutaneous Dilatational Tracheostomy in Critically Ill Patients in Intensive Care Units. Chang HL, Yang CJ, Hung JY, Hung CF, Su YC, Chong IW, Hwang JJ, Huang MS, Sheu CC, Tsai JR J Intern Med Taiwan 2013; 24: 153-161ISI: Original articles

門診時間表

上午診

看診日期:1090820 星期 4 診間號:0141
看診日期:1090827 星期 4 診間號:0141
看診日期:1090903 星期 4 診間號:0141
看診日期:1090910 星期 4 診間號:0141
看診日期:1090917 星期 4 診間號:0141
看診日期:1090924 星期 4 診間號:0141
看診日期:1091008 星期 4 診間號:0141
看診日期:1091015 星期 4 診間號:0141

下午診

看診日期:1090817 星期 1 診間號:0141
看診日期:1090824 星期 1 診間號:0141
看診日期:1090831 星期 1 診間號:0141
看診日期:1090907 星期 1 診間號:0141
看診日期:1090914 星期 1 診間號:0141
看診日期:1090921 星期 1 診間號:0141
看診日期:1090928 星期 1 診間號:0141
看診日期:1091005 星期 1 診間號:0141
看診日期:1091012 星期 1 診間號:0141

夜間診

查無看診日期

 

總機電話:(07) 291-1101     人工掛號專線:(07)2911-361    語音掛號專線:(07)2911-331    意見反映專線:07-291-1101轉8934

聯絡地址:80145 高雄市前金區中華三路68號   Kaohsiung Municipal Ta-Tung Hospital , Kaohsiung City 801, Taiwan (R.O.C.)

建議使用IE6 以上瀏覽器 最佳解析度為1024x768 網站維護:資訊室